What Happened? Shares of healthcare company Baxter International (NYSE:BAX) fell 4.5% in the afternoon session after Barclays ...
Q4 sales performance exceeded guidance, driven by better-than-expected sales in Medical Products, Kidney Care, Pharmaceuticals. Baxter reported improved profitability in fourth quarter. Brand New ...
As Baxter International Inc (NYSE:BAX) prepares to release its second-quarter 2023 financial results on July 27, Stifel analyst writes it is an opportune time for investors to consider owning BAX ...